UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)

PloS one, 2012-02, Vol.7 (2), p.e26331-e26331

2012

Volltextzugriff (PDF)

A Phase Ib Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1024-e89

2017

Volltextzugriff (PDF)

Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours

European journal of cancer (1990), 2006-05, Vol.42 (7), p.864-870

2006

Volltextzugriff (PDF)

Evidence of Determinant Spreading in the Antibody Responses to Prostate Cell Surface Antigens in Patients Immunized with Prostate-specific Antigen

Clinical cancer research, 2002-02, Vol.8 (2), p.368-373

2002

Volltextzugriff (PDF)

A Phase I study of 9‐nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

Cancer, 2003-01, Vol.97 (1), p.148-154

2003

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Ecteinascidin 743 Administered as a 72-Hour Continuous Intravenous Infusion in Patients with Solid Malignancies

Clinical cancer research, 2001-02, Vol.7 (2), p.231-242

2001

Volltextzugriff (PDF)

Abstract LB215: Polymerase θ (POLθ) inhibitors (novobiocin, ART-558, RP6685) were tested with 22 approved and investigational agents in multi-cell type spheroids of genetically selected patient-derived human tumor cell lines

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB215-LB215

2024

Volltextzugriff (PDF)

Sequential doxorubicin and topotecan in relapsed refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906

Leukemia & lymphoma, 2006-08, Vol.47 (8), p.1511-1517

2006

Volltextzugriff (PDF)

Identifying treatment options for BRAF.sup.V600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

PloS one, 2021-04, Vol.16 (4), p.e0248097

2021

Volltextzugriff (PDF)

Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-339-LB-339

2018

Volltextzugriff (PDF)

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Journal of clinical oncology, 1992-06, Vol.10 (6), p.995-1000

1992

Volltextzugriff (PDF)

Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents

Cancer research (Chicago, Ill.), 1989-02, Vol.49 (3), p.595-598

1989

Volltextzugriff (PDF)

Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan

Blood, 2004-11, Vol.104 (11), p.2500-2500

2004

Volltextzugriff (PDF)

Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line

The Journal of biological chemistry, 1993-01, Vol.268 (3), p.2160-2165

1993

Volltextzugriff (PDF)

High-dose ifosfamide with mesna uroprotection: a phase I study

Journal of clinical oncology, 1990-01, Vol.8 (1), p.170-178

1990

Volltextzugriff (PDF)

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (7), p.559-566

1993

Volltextzugriff (PDF)

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

Journal of clinical oncology, 1990-04, Vol.8 (4), p.648-656

1990

Volltextzugriff (PDF)

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas

Journal of clinical oncology, 1990-10, Vol.8 (10), p.1699-1706

1990

Volltextzugriff (PDF)

Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase IIα Gene (∗)

The Journal of biological chemistry, 1995-10, Vol.270 (43), p.25850-25858

1995

Volltextzugriff (PDF)

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

Journal of clinical oncology, 1991-02, Vol.9 (2), p.320-327

1991

Volltextzugriff (PDF)

Irinotecan and radiation in vitro and in vivo

International journal of oncology, 1997-12

1997

Volltextzugriff (PDF)

Phase I trial of escalating pentoxifylline dose with constant dose thiotepa

Cancer research (Chicago, Ill.), 1990-11, Vol.50 (21), p.6806-6810

1990

Volltextzugriff (PDF)

Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase II Gene

The Journal of biological chemistry, 1995-10, Vol.270 (43), p.25850

1995

Volltextzugriff (PDF)

Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo

Cancer research (Chicago, Ill.), 1989-11, Vol.49 (21), p.5994

1989

Volltextzugriff (PDF)

Modulation of alkylating agents by etanidazole and fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma

Cancer research (Chicago, Ill.), 1991-02, Vol.51 (4), p.1086-1091

1991

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Life Sciences & Biomedicine
(86)
Humans
(67)
Female
(48)
Male
(42)
Middle Aged
(39)
Adult
(36)
Oncology
(36)
Biological And Medical Sciences
(34)
Medical Sciences
(29)
Aged
(27)
Animals
(24)
Antineoplastic Agents
(23)
Pharmacology. Drug Treatments
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(21)
Chemotherapy
(17)
Mice
(16)
Dose-Response Relationship, Drug
(15)
Physical Sciences
(13)
Technology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)

A Phase Ib Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS

Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours

Evidence of Determinant Spreading in the Antibody Responses to Prostate Cell Surface Antigens in Patients Immunized with Prostate-specific Antigen

A Phase I study of 9‐nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

Phase I and Pharmacokinetic Study of Ecteinascidin 743 Administered as a 72-Hour Continuous Intravenous Infusion in Patients with Solid Malignancies

Abstract LB215: Polymerase θ (POLθ) inhibitors (novobiocin, ART-558, RP6685) were tested with 22 approved and investigational agents in multi-cell type spheroids of genetically selected patient-derived human tumor cell lines

Sequential doxorubicin and topotecan in relapsed refractory aggressive non-Hodgkin's lymphoma: Results of CALGB 59906

Identifying treatment options for BRAF.sup.V600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents

Sequential Topoisomerase I (Topo I) and Topoisomerase II (Topo II) Inhibitors in Relapsed/Refractory Aggressive NHL: Results of CALGN 59906, a Phase II Study of Doxorubicin and Topotecan

Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line

High-dose ifosfamide with mesna uroprotection: a phase I study

Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas

Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase IIα Gene (∗)

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support

Irinotecan and radiation in vitro and in vivo

Phase I trial of escalating pentoxifylline dose with constant dose thiotepa

Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase II Gene

Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo

Modulation of alkylating agents by etanidazole and fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma

Suchergebnisse filtern